UCB's Global Corporate Website

This section is intended for media and financial analysts

Search Press releases

20 Mar 2008

UCB advises US-physicians to down-titrate patients on Neupro® in view of out-of-stock situation in the US

Read More
4 Mar 2008

UCB: Early Data on Cimzia® from the WELCOME Study Show Efficacy in Infliximab-Refractory Crohn's Disease Patients

Read More
3 Mar 2008

Changes in UCB's Executive Committee

Read More
29 Feb 2008

UCB: Full Year 2007 Financial Results

Read More
19 Feb 2008

FDA Approves XYZAL® (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria

Read More
6 Feb 2008

FDA Agrees to Review Cimzia® File for the Treatment of Rheumatoid Arthritis

Read More

Stay up-to-date on the latest news and information from UCB